ThacherTDFischerPRStrandMAPettiforJM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006;26:1-16.
2.
van SchoorNMVisserMPluijmSMKuchukNSmitJHLipsP. Vitamin D deficiency as a risk factor for osteoporotic fractures. Bone. 2008;42:260-266.
3.
PittMJ. Rickets and osteomalacia are still around. Radiol Clin North Am. 1991;29:97-118.
4.
AllgroveJMughalMZ. Calcium deficiency rickets: extending the spectrum of “nutritional” rickets. Arch Dis Child. 2014;99:794-795.
5.
HolickMFRichtandNMMcNeillSC. Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiation. Biochemistry. 1979;18:1003-1008.
6.
HolickMF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
7.
HolickMFTianXQAllenM. Evolutionary importance for the membrane enhancement of the production of vitamin D3 in the skin of poikilothermic animals. Proc Natl Acad Sci U S A. 1995;92:3124-3126.
8.
NormanAW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr. 1998;67:1108-1110.
9.
AdamsJSHewisonM. Update in vitamin D. J Clin Endocrinol Metab. 2010;95:471-478.
10.
HolickMFBinkleyNCBischoff-FerrariHA. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
11.
BrenzaHLDeLucaHF. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression by parathyroid hormone and 1,25-dihydroxyvitamin D3. Arch Biochem Biophys. 2000;381:143-152.
12.
RobinsonCJSpanosEJamesMF. Role of prolactin in vitamin D metabolism and calcium absorption during lactation in the rat. J Endocrinol. 1982;94:443-453.
13.
PikeJWSpanosEColstonKWMacIntyreIHausslerMR. Influence of estrogen on renal vitamin D hydroxylases and serum 1alpha,25-(OH)2D3 in chicks. Am J Physiol. 1978;235:E338-E343.
14.
DeLucaHF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 suppl):1689S-1696S.
15.
MacDonaldPNDowdDRNakajimaS. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol. 1993;13:5907-5917.
16.
PfeiferMBegerowBMinneHW. Vitamin D and muscle function. Osteoporos Int. 2002;13:187-194.
17.
NormanAW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006;147:5542-5548.
18.
ChristakosSDhawanPLiuYPengXPortaA. New insights into the mechanisms of vitamin D action. J Cell Biochem. 2003;88:695-705.
19.
HeaneyRPDowellMSHaleCABendichA. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003;22(2):142-146.
20.
DussoASBrownAJSlatopolskyE. Vitamin D. Am J Physiol Renal Physiol. 2005;289:F8-F28.
21.
XueYKaraplisACHendyGNGoltzmanDMiaoD. Exogenous 1,25-dihydroxyvitamin D3 exerts a skeletal anabolic effect and improves mineral ion homeostasis in mice that are homozygous for both the 1alpha-hydroxylase and parathyroid hormone null alleles. Endocrinology. 2006;147:4801-4810.
22.
HorwoodNJElliottJMartinTJGillespieMT. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology. 1998;139:4743-4746.
23.
Bischoff-FerrariHAGiovannucciEWillettWCDietrichTDawson-HughesB. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28.
24.
BookoutALJeongYDownesMYuRTEvansRMMangelsdorfDJ. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell. 2006;126:789-799.
25.
NormanAW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:491S-499S.
26.
HayesCENasholdFESpachKMPedersenLB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003;49:277-300.
27.
MisraMPacaudDPetrykACollett-SolbergPFKappyM. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398-417.
28.
RossACMansonJEAbramsSA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58.
29.
CallaghanALMoyRJBoothIWDebelleGShawNJ. Incidence of symptomatic vitamin D deficiency. Arch Dis Child. 2006;91:606-607.
30.
TurerCBLinHFloresG. Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics. 2013;131:e152-e161.
31.
GordonCMDePeterKCFeldmanHAGraceEEmansSJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med. 2004;158:531-537.
32.
SullivanSSRosenCJHaltemanWAChenTCHolickMF. Adolescent girls in Maine are at risk for vitamin D insufficiency. J Am Diet Assoc. 2005;105:971-974.
33.
LookerACPfeifferCMLacherDASchleicherRLPiccianoMFYetleyEA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88:1519-1527.
34.
ShaikhUAlpertPT. Nutritional rickets in Las Vegas, Nevada. J Pediatr Endocrinol Metab. 2006;19:209-212.
35.
GessnerBDdeSchweinitzEPetersenKMLewandowskiC. Nutritional rickets among breast-fed black and Alaska Native children. Alaska Med. 1997;39(3):72-74, 87.
36.
ZieglerEEHollisBWNelsonSEJeterJM. Vitamin D deficiency in breastfed infants in Iowa. Pediatrics. 2006;118:603-610.
37.
ShahMSalhabNPattersonDSeikalyMG. Nutritional rickets still afflict children in north Texas. Tex Med. 2000;96(6):64-68.
38.
HolickMFChenTCLuZSauterE. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res. 2007;22(suppl 2):V28-V33.
39.
MoanJPorojnicuACDahlbackASetlowRB. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A. 2008;105:668-673.
40.
ClemensTLAdamsJSHendersonSLHolickMF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982;1:74-76.
41.
HintzpeterBScheidt-NaveCMullerMJSchenkLMensinkGB. Higher prevalence of vitamin D deficiency is associated with immigrant background among children and adolescents in Germany. J Nutr. 2008;138:1482-1490.
42.
WortsmanJMatsuokaLYChenTCLuZHolickMF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-693.
43.
YinMSteinE. The effect of antiretrovirals on vitamin D. Clin Infect Dis. 2011;52:406-408.
44.
AllavenaCDelpierreCCuzinL. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J Antimicrob Chemother. 2012;67:2222-2230.
45.
PackAM. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3(3):91-95.
46.
VestergaardP. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs. 2015;17:141-150.
47.
HolickMF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373.
48.
AaronJEGallagherJCAndersonJ. Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet. 1974;1:229-233.
49.
RobinsonPDHoglerWCraigME. The re-emerging burden of rickets: a decade of experience from Sydney. Arch Dis Child. 2006;91:564-568.
50.
SchottGDWillsMR. Muscle weakness in osteomalacia. Lancet. 1976;1:626-629.
51.
ZiambarasKDagogo-JackS. Reversible muscle weakness in patients with vitamin D deficiency. West J Med. 1997;167:435-439.
52.
YorifujiJYorifujiTTachibanaK. Craniotabes in normal newborns: the earliest sign of subclinical vitamin D deficiency. J Clin Endocrinol Metab. 2008;93:1784-1788.
53.
RauchF. The rachitic bone. Endocr Dev. 2003;6:69-79.
54.
WangJTLinCJBurridgeSM. Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families. Am J Hum Genet. 1998;63:1694-1702.
55.
MalloyPJFeldmanD. Genetic disorders and defects in vitamin D action. Rheum Dis Clin North Am. 2012;38:93-106.
56.
AllgroveJ. Physiology of calcium, phosphate and magnesium. Endocr Dev. 2009;16:8-31.
57.
ChengJBLevineMABellNHMangelsdorfDJRussellDW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004;101:7711-7715.
58.
KitanakaSTakeyamaKMurayamaA. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med. 1998;338:653-661.
59.
LabudaMMorganKGlorieuxFH. Mapping autosomal recessive vitamin D dependency type I to chromosome 12q14 by linkage analysis. Am J Hum Genet. 1990;47:28-36.
60.
ScriverCRReadeTMDeLucaHFHamstraAJ. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease. N Engl J Med. 1978;299:976-979.
61.
FanconiAPraderA. Hereditary pseudo-vitamin D deficiency rickets. Helv Paediatr Acta. 1969;24:423-447.
62.
ZambranoMNikitakisNGSanchez-QuevedoMCSaukJJSedanoHRiveraH. Oral and dental manifestations of vitamin D-dependent rickets type I: report of a pediatric case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95:705-709.
63.
De BraekeleerM. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). Hum Hered. 1991;41:141-146.
64.
BalsanSGarabedianMCourtecuisseV. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with “pseudo-deficiency” rickets. Clin Endocrinol (Oxf). 1977;7(Suppl):225s-230s.
65.
DelvinEEGlorieuxFHMariePJPettiforJM. Vitamin D dependency: replacement therapy with calcitriol?J Pediatr. 1981;99:26-34.
66.
EdouardTAlosNChabotGRoughleyPGlorieuxFHRauchF. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J Clin Endocrinol Metab. 2011;96:82-89.
67.
CasellaSJReinerBJChenTCHolickMFHarrisonHE. A possible genetic defect in 25-hydroxylation as a cause of rickets. J Pediatr. 1994;124:929-932.
68.
ZerwekhJEGlassKJowseyJPakCY. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 1979;49:171-175.
69.
LinCJDardisAWijesuriyaSDAbdullahMACasellaSJMillerWL. Lack of mutations in CYP2D6 and CYP27 in patients with apparent deficiency of vitamin D 25-hydroxylase. Mol Genet Metab. 2003;80:469-472.
70.
AsamiTKawasakiTUchiyamaM. Unique form of rickets with low serum 25-hydroxyvitamin D in two normally nourished children. Acta Paediatr Jpn. 1995;37:182-188.
71.
NutzenadelWMehlsOKlausG. A new defect in vitamin D metabolism. J Pediatr. 1995;126:676-677.
72.
AbdullahMASalhiHSBakryLA. Adolescent rickets in Saudi Arabia: a rich and sunny country. J Pediatr Endocrinol Metab. 2002;15:1017-1025.
73.
HausslerMRMangelsdorfDJKommBS. Molecular biology of the vitamin D hormone. Recent Prog Horm Res. 1988;44:263-305.
74.
BrooksMHBellNHLoveL. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med. 1978;298:996-999.
75.
KudohTKumagaiTUetsujiN. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur J Pediatr. 1981;137:307-311.
76.
MarxSJSpiegelAMBrownEM. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978;47:1303-1310.
77.
HughesMRMalloyPJKiebackDG. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 1988;242:1702-1705.
78.
LibermanUAEilCMarxSJ. Resistance to 1,25-dihydroxyvitamin D. Association with heterogeneous defects in cultured skin fibroblasts. J Clin Invest. 1983;71:192-200.
79.
BalsanSGarabedianMLibermanUA. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab. 1983;57:803-811.
80.
BeerSTiederMKoheletD. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25-dihydroxy vitamin D. Clin Endocrinol (Oxf). 1981;14:395-402.
81.
FeldmanDChenTConeC. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab. 1982;55:1020-1022.
82.
HochbergZBenderliALevyJ. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med. 1984;77:805-811.
83.
HirstMAHochmanHIFeldmanD. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J Clin Endocrinol Metab. 1985;60:490-495.
84.
TakedaEKurodaYSaijoT. 1-Alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics. 1987;80:97-101.
85.
YagiHOzonoKMiyakeHNagashimaKKuroumeTPikeJW. A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant rickets. J Clin Endocrinol Metab. 1993;76:509-512.
86.
NishinoMKamadaKAritaKTakaradaT. Dentofacial manifestations in children with vitamin D-dependent Rickets type II. Shoni Shikagaku Zasshi. 1990;28:346-358.
87.
RosenJFFleischmanARFinbergLHamstraADeLucaHF. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr. 1979;94:729-735.
88.
LibermanUASamuelRHalabeA. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet. 1980;1:504-506.
FraherLJKarmaliRHindeFR. Vitamin D-dependent rickets type II: extreme end organ resistance to 1,25-dihydroxy vitamin D3 in a patient without alopecia. Eur J Pediatr. 1986;145:389-395.
91.
MarxSJBliziotesMMNanesM. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf). 1986;25:373-381.
92.
StumpfWESarMReidFATanakaYDeLucaHF. Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979;206:1188-1190.
93.
BergerUWilsonPMcClellandRA. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988;67:607-613.
94.
MalloyPJTasicVTahaD. Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab. 2014;111:33-40.
95.
TakedaEYokotaIKawakamiIHashimotoTKurodaYAraseS. Two siblings with vitamin-D-dependent rickets type II: no recurrence of rickets for 14 years after cessation of therapy. Eur J Pediatr. 1989;149:54-57.
96.
ChenTLHirstMAConeCMHochbergZTietzeHUFeldmanD. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents. J Clin Endocrinol Metab. 1984;59:383-388.
97.
WeismanYJaccardNLegumC. Prenatal diagnosis of vitamin D-dependent rickets, type II: response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues. J Clin Endocrinol Metab. 1990;71:937-943.
98.
GiraldoAPinoWGarcia-RamirezLFPinedaMIglesiasA. Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children. Clin Genet. 1995;48:57-65.
99.
HewisonMRutARKristjanssonK. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol (Oxf). 1993;39:663-670.
100.
ChenHHewisonMAdamsJS. Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance: a novel response element-binding protein. J Biol Chem. 2006;281:39114-39120.
